246720.KQ ASTA Corporation
- Market cap
- KRW 99.4B
- P/E
- -
- P/B
- 5.47x
- ROE
- -26.4%
- Dividend yield
- -
- Fundamental score
- 0.5/5
Ratios use the latest price and the current fiscal year annualized from 2 quarters up to Jun 2026.
Is 246720.KQ undervalued?
Graham numberThe Graham number of ASTA Corporation cannot be estimated reliably (it needs positive earnings and book value).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
ASTA Corporation fundamental analysis
3 of 21 checks passedROE 0/2
Low return on equity (-26.4%), below 10%.
ROA 0/1
Return on assets (-21.4%) is below the industry median (-2.3%).
Profit Consistency 0/2
Not profitable for at least 3 consecutive years.
Earnings Growth 5Y 0/1
Earnings per share history is shorter than 5 years.
Earnings Acceleration 0/1
Not enough positive earnings history to compare last year's growth with the 5-year average.
Earnings Growth vs Industry 1/1
Last year's EPS growth (29.2%) is above the industry median (-27.9%).
Revenue Growth 0/2
Revenue shrank 8.1% a year over the past 3 years.
Short-term Liquidity 1/1
Current assets cover short-term liabilities.
Long-term Liabilities 1/1
Current assets cover long-term liabilities.
Debt to Equity 0/2
Debt to equity cannot be calculated: debt is not reported or equity is negative.
Debt Trend 0/1
Debt to equity has risen over the past 5 years.
Cash Runway 0/2
Cash covers 0.8 years of the current cash burn.
PE vs Market 0/1
PE is negative or not available.
PE vs Industry 0/1
PE is negative or not available.
PBV 0/1
Price to book (5.5x) is above the industry median (1.2x).
Graham Number 0/1
Graham number needs positive earnings and book value.
PEG 0/1
PEG needs positive PE and positive 5-year earnings growth.
Dividend Yield 0/2
No dividend paid in the last reported year.
Dividend Stability 0/2
Dividends were not paid steadily for the past 5 years.
Dividend Growth 0/1
Dividends paid did not grow over the past 5 years.
Payout Ratio 0/1
No dividend, or no profit to pay it from.
Each check is worth 1 or 2 points by how much it says about the quality of the company. The score is the share of points earned, out of 5. Ask AI to explain this score
ASTA Corporation stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About ASTA Corporation
ASTA Corporation engages in the development of diagnosis solutions in South Korea. The company offers microorganism identification systems, such as MicroIDSys and MicroIDSys Elite, which is used for applications in the areas of rapid diagnosis of infectious diseases, food hygiene management, agriculture and stockbreeding quarantines, and prevention of bio-terrorism. It also provides IDSys LT/RT, a MALDI-TOF mass spectrometry solution; NosIDSys, an economical diagnostic syste…
Full company profileASTA Corporation financial statements
2026 annualized: Fiscal year 2026 is not finished. Income statement and cash flow are annualized from 2 quarters up to Jun 30, 2026, the balance sheet is the latest quarter. Figures change when the annual report is published.
ASTA Corporation annual financial statements (KRW; K = thousand, M = million, B = billion, T = trillion)
| Item | 2022 | 2023 | 2024 | 2025 | 2026 Anlz |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | 3.35B | 3.13B | 3.35B | 2.59B | 3.27B |
| Gross Profit | 1.56B | 1.58B | 958M | 1.26B | 1.20B |
| Operating Income | -2.78B | -2.72B | -4.02B | -2.59B | -3.86B |
| EBITDA | -1.85B | -1.72B | -2.91B | -2.45B | -3.41B |
| Net Income | -2.80B | -2.81B | -3.86B | -3.30B | -4.62B |
| EPS | -217 | -213 | -285 | -202 | -282 |
| Balance Sheet | |||||
| Total Assets | 10.9B | 9.71B | 8.56B | 15.5B | 21.6B |
| Total Liabilities | 3.70B | 3.54B | 4.41B | 6.27B | 4.08B |
| Shareholders' Equity | 7.24B | 6.17B | 4.15B | 9.22B | 17.5B |
| Cash & Short-term Investments | 3.17B | 1.38B | 21.3M | 2.91B | 9.33B |
| Cash Flow | |||||
| Operating Cash Flow | -1.63B | -4.03B | -2.11B | -3.35B | -4.36B |
| Capital Expenditure | 229M | 18.3M | 454M | 29.6M | 7.74B |
| Free Cash Flow | -1.85B | -4.05B | -2.57B | -3.38B | -12.1B |
| Ratios | |||||
| ROE | -38.7% | -45.6% | -93.2% | -35.8% | -26.4% |
| ROA | -25.6% | -29.0% | -45.1% | -21.3% | -21.4% |
| Net Profit Margin | -83.7% | -89.8% | -115.2% | -127.3% | -141.2% |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
ASTA Corporation dividends
ASTA Corporation has not paid dividends in the last 4 fiscal years.
Who owns ASTA Corporation
- Insiders 45.58%
- Institutions 0.00%
- Public & others 54.42%
- Shares outstanding 16.4M
- Free float 7.87M
ASTA Corporation company profile
- Company name
- ASTA Corporation
- Ticker
- 246720.KQ
- Exchange
- KOSDAQ
- Sector
- Healthcare
- Industry
- Medical Instruments & Supplies
- Employees
- 26
- Fiscal year end
- December
- Address
- AICT Building A, Suwon-si, South Korea, 16229
- Phone
- 82 3 1893 0375
- Website
- astams.com
About ASTA Corporation
ASTA Corporation engages in the development of diagnosis solutions in South Korea. The company offers microorganism identification systems, such as MicroIDSys and MicroIDSys Elite, which is used for applications in the areas of rapid diagnosis of infectious diseases, food hygiene management, agriculture and stockbreeding quarantines, and prevention of bio-terrorism. It also provides IDSys LT/RT, a MALDI-TOF mass spectrometry solution; NosIDSys, an economical diagnostic system used for diagnosis and prevention of rare incurable diseases, such as cancer and degenerative brain diseases; LDI-TOF, an laser desorption ionization time of flight mass spectrometer for OLED analysis and test; MALDI Plate, a disposable plate; and rapid enzyme digestion system. In addition, the company provides diagnostics software. ASTA Corporation was founded in 2006 and is based in Suwon-si, South Korea.
ASTA Corporation management
4- Mr. Eung-Joon JoCEO & Chairman · born 1954
- Ms. Yang-Sun KimChief Executive Officer and Director · born 1958
- Mr. Eung-Su ChoPresident and Head of Overall Business Management · born 1955
- Ms. Sook-Hwa KwonHead of Sales and Managing Director · born 1967